Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study

Ashina Messoud; Dodick David; Goadsby Peter J.Reuter UweSilberstein StephenZhang FengGage Julia R.Cheng SunfaMikol Daniel D.Lenz Robert A.

首页> 外文期刊>Neurology: Official Journal of the American Academy of Neurology >Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study

【24h】

Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study

机译：在情景性偏头痛期间Erenumab (AMG 334)一个正在进行的开放研究的分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess long-term safety and efficacy of anti-calcitonin gene-related peptide receptor erenumab in patients with episodic migraine (EM).

机译：目的:评估长期的安全性和有效性的anti-calcitonin相关基因肽受体erenumab情景性偏头痛患者(EM)。

著录项

来源
《Neurology: Official Journal of the American Academy of Neurology》 |2017年第12期|1237-1243|共7页
作者
Ashina Messoud; Dodick David; Goadsby Peter J.Reuter UweSilberstein StephenZhang FengGage Julia R.Cheng SunfaMikol Daniel D.Lenz Robert A.;
展开▼
作者单位

Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache Ctr,Dept Neurol, Copenhagen;

Mayo Clin, Dept Neurol, Scottsdale, AZ USA;

Charite, Dept Neurol, Berlin, GermanyGage Med Writing LLC, Moorpark, CA USAAmgen Inc, Thousand Oaks, CA 91320 USAThomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USAKings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类神经病学;
关键词
Peptide Receptor; Migraine Disorders;

机译：肽受体;偏头痛障碍;

相似文献

外文文献
中文文献

1. A central analgesic mechanism of acupuncture for migraine An ongoing functional MRI study** [J] . Lei Lan, Yujie Gao, Fang Zeng, 中国神经再生研究（英文版） . 2013,第28期
2. Efficacy of Lycium barbarum polysaccharide in adolescents with subthreshold depression: interim analysis of a randomized controlled study [J] . Xiaoyue Li, Xuan Mo, Tao Liu, 中国神经再生研究（英文版） . 2022,第7期
3. Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study [J] . Adrian Viudez‐Martínez, Angela Pascual‐Carrasco, Isabel Beltrán‐BlascoRaquel Hernandez‐LoridoRosa F.?Ruiz?de?Apodaca Journal of clinical pharmacy and therapeutics. . 2022,第6期

机译：Effectiveness and safety of erenumab and galcanezumab in the prevention of chronic and episodic migraine: A retrospective cohort study
4. Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study [J] . Jonathan Gladstone, Sameer Chhibber, Jagdeep MinhasCalum S. NeishG. Sarah PowerZhiyi LanDriss RochdiJessica Lanthier‐MartelNatacha Bastien Headache . 2022,第1期

机译：Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
5. Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study [J] . Ferrari Michel Dominique, Reuter Uwe, Goadsby Peter J.Lima Gabriel Paiva da SilvaMondal SubhayanWen ShihuaTenenbaum NadiaPandhi ShalooLanteri-Minet MichelStites Tracy Journal of Neurology, Neurosurgery and Psychiatry . 2022,第3期

机译：Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study
6. Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects [O] . Thuy Vu, Peiming Ma, Jiyun Sunny Chen, -1

机译：Erenumab（AMG 334）与辣椒素诱导的健康和偏头痛受试者皮肤血流的药代动力学-药效关系
7. Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers [O] . Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, 2018

机译：第1阶段，随机，平行组，双盲，安慰剂对照试验，以评估Erenumab（AMG 334）的影响和伴随苏拉普坦对健康志愿者的血压

Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study

摘要

著录项

相似文献

相关主题

期刊订阅